Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by OPTIMI HEALTH CORP.
Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial
June 10, 2026
From
OPTIMI HEALTH CORP.
Via
GlobeNewswire
Tickers
CSE:OPTI
OPTH
Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development
June 08, 2026
From
OPTIMI HEALTH CORP.
Via
GlobeNewswire
Tickers
CSE:OPTI
OPTH
Optimi Health Completes Commercial Psilocybin Production to Address Treatment-Resistant Depression in Australia
June 02, 2026
From
OPTIMI HEALTH CORP.
Via
GlobeNewswire
Tickers
CSE:OPTI
OPTH
Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia
May 29, 2026
From
OPTIMI HEALTH CORP.
Via
GlobeNewswire
Tickers
CSE:OPTI
OPTH
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.